$Orgenesis(ORGS.US)$Orgenesis-Enteredinto Asset Purchase and Strategic Collaboration Agreement Which to Provide Octomera With Over $8 Mln of Initial Collaboration Payments
$Orgenesis(ORGS.US)$ NEWS Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility Germfree and Orgenesis Inc. announce a strategic partnership to advance cell and gene therapy production. The collaboration aims to reduce production costs, increase accessibility to treatments, and revolutionize the bio-manufacturing industry. Orgenesis will co-market its Octomera platform wit...
$Orgenesis(ORGS.US)$Press Release: Orgenesis Consortium Awarded EUR2.0M EUR Grant From Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing Dow Jones· just
Investors expect Orgenesis' limited growth rates to persist due to its declining revenue growth and lower P/S ratio compared to industry peers. Without revenue improvement, share price recovery seems unlikely.
$Orgenesis(ORGS.US)$Benzinga· 3 mins ago Orgenesis has entered into a definitive agreement with MM OS Holdings, an affiliate of Metalmark Capital Partners, to acquire its approximate 25% stake in Octomera. Octomera is Orgenesis's cell processing services subsidiary, and the transaction allows the company to have 100% ownership of this business unit. In exchange, Metalmark will receive a royalty of 5% of the net revenue of Octomera's cell processing services for the three calendar years 2025-...
$Orgenesis(ORGS.US)$Orgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant Funding 2 MINUTES AGO, 8:00 AM EDT VIA GLOBENEWSWIRE
Trytosaveabit樓主 : 奧創股份有限公司-展望未來,我們的轉型第一步是近期交易重獲 Octomera 100% 所有權